Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

AbbVie Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (148)
Cancellation by sponsor (87)
Prescription medicine registration (25)
Australian public assessment report (AusPar) (22)
Designation or determination (7)
Prescription medicine evaluation (2)
Prescription medicine decision summary (1)
Section 14, TGO91 consent (1)

Date

2025 (27)
2024 (26)
2023 (26)
2022 (14)
2021 (14)
2020 (20)
2019 (24)
2018 (14)
2017 (29)
2016 (5)
2015 (19)
2014 (28)
2013 (4)
2012 (4)
2011 (4)
2010 (5)
2009 (4)
2008 (3)
2007 (1)
2006 (4)
2005 (4)
2002 (2)
2001 (1)
1999 (1)
1998 (1)
1997 (1)
1996 (1)
1994 (2)
1991 (5)

Search

Sponsor content

293 result(s) found, displaying 181 to 190

VENCLEXTA (Abbvie Pty Ltd)

8 October 2018

Prescription medicine registration

Active ingredients: venetoclax.
Abbvie Pty Ltd - Medicine administration kit, percutaneous, medicated, single-use (252515)

3 August 2015

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Abbvie Pty Ltd - Medicine administration kit, percutaneous, medicated, single-use.
TECHNIVIE paritaprevir/ritonavir/ombitasvir 75mg/50mg/12.5mg tablets fixed dose combination blister pack Cancelled under Section 30(1)(c) of the Act

31 July 2018

Cancellation by sponsor

Requested by Abbvie Pty Ltd
SYNAGIS palivizumab (rmc) powder for injection 50mg/0.5mL (reconstituted) per vial with diluent ampoule Cancelled under Section 30(1)(c) of the Act

25 July 2018

Cancellation by sponsor

Requested by Abbvie Pty Ltd
SYNAGIS palivizumab (rmc) powder for injection 100mg/mL (reconstituted) per vial with diluent ampoule Cancelled under Section 30(1)(c) of the Act

25 July 2018

Cancellation by sponsor

Requested by Abbvie Pty Ltd
OZURDEX dexamethasone 700 microgram Intravitreal implant (222392)

4 June 2015

ARTG

Australian Register of Therapeutic Goods (ARTG) information for OZURDEX dexamethasone 700 microgram Intravitreal implant.
LUCRIN DEPOT leuprorelin acetate 45mg powder for suspension prefilled dual-chamber syringe injection (222375)

12 May 2015

ARTG

Australian Register of Therapeutic Goods (ARTG) information for LUCRIN DEPOT leuprorelin acetate 45mg powder for suspension prefilled dual-chamber syringe injection.
Abbvie Pty Ltd - Lubricant, eye (235722)

1 April 2015

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Abbvie Pty Ltd - Lubricant, eye.
Abbvie Pty Ltd - Lubricant, eye (235723)

1 April 2015

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Abbvie Pty Ltd - Lubricant, eye.
Abbvie Pty Ltd - Lubricant, eye (235724)

1 April 2015

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Abbvie Pty Ltd - Lubricant, eye.

Pages

First page
Previous page
…
Page 15
Page 16
Page 17
Page 18
Current page 19
Page 20
Page 21
Page 22
Page 23
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.